Chikashi Shibata

Tohoku Medical and Pharmaceutical University Hospital

Papers

1

Total Citations

1

H-Index

1

About

Chikashi Shibata is a leading authority in hepatobiliary and pancreatic surgery, with a focused expertise in the management of biliary tract cancer (BTC). His major contributions center on refining treatment strategies for this rare and challenging malignancy, where tumor location—whether in the hilar bile ducts or gallbladder—dramatically influences both surgical invasiveness and prognosis. Shibata’s work critically addresses the persistently high perioperative mortality rates in high-risk BTC subtypes, advocating for tailored, site-specific approaches to improve patient outcomes. His recent 2025 review, which has already garnered early citations, synthesizes current insights and future perspectives on multimodal therapy, including surgical innovation and perioperative care. By highlighting benchmark cases and identifying key areas for clinical improvement, Shibata’s research provides a vital roadmap for surgeons and oncologists navigating the complexities of BTC. His ongoing efforts to reduce mortality and optimize treatment protocols underscore his impact on advancing surgical oncology for patients with limited therapeutic options.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Current insights and future perspectives of treatment strategies for biliary tract cancer
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Tohoku Medical and Pharmaceutical University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago